Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Profound Medical Corp.
< Previous
1
2
Next >
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Today 8:45 EST
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
November 11, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
November 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
October 16, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
October 07, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
August 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
July 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
June 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
June 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
May 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces First Quarter 2025 Financial Results
May 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
April 29, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
April 17, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical AUA 2025 Investor Event Agenda
April 15, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Save the Date: Profound Medical to Host Investor Event at AUA 2025
March 25, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
March 06, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
February 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
January 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
January 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
December 10, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Tickers
PROF
TSX:PRN
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today